Results for:

Vaccines

< Back to all posts

Why is vaccine rollout so slow!?!

Vaccines

Q: Why can’t we get available vaccine doses administered more quickly? A: Many factors: The holidays, lack of funding, staffing and logistical challenges, getting large-scale vaccine operations up and running, sticking to prioritization schemes, and lower take-up among high-priority groups. Things should be speeding up in the next few weeks. It’s frustrating to see statistics Read more…

Should I be worried about potential long-term side effects of COVID-19 vaccines?

Vaccines

A: Realistically, no. Biologically, the chances of long-term effects are vanishingly small. TL;DR: Serious vaccine side effects are exceedingly rare and occur hours or days after vaccination, not months or years. The risk of infection and long-term health effects of COVID-19 infection are high and very real. We *really* feel the sentiment behind this common Read more…

Why do we need two doses of the COVID-19 vaccine? Can we use one dose and vaccinate more people?

Vaccines

A: A two dose schedule was proven to work and authorized for both the Pfizer and Moderna COVID-19 vaccines. One dose provides sub-optimal immunity and has not been studied in clinical trials designed to test their efficacy. Giving one dose of these vaccines to the most vulnerable populations would leave them without full immune protection. Read more…

Who will get the COVID vaccines next?

Vaccines

A: The next group to be vaccinated, with the catchy title “Phase 1b”, will include people who are 75 years and older, plus frontline essential workers. That includes 👩‍🏫teachers, educational support staff & daycare workers; 👩‍🚒 firefighters & police; 👩‍🌾 food & agriculture workers; ⚖️ jail and prison staff; 📮 postal workers; 🚍 public transit Read more…

How can I help encourage my colleagues in healthcare settings to get the Covid-19 vaccination?

Uncertainty and Misinformation Vaccines

A: Personal beliefs and experiences inform varying levels of acceptance of the Covid-19 vaccine now becoming available to essential workers in healthcare settings. Listen to the reasons for concern, respond with compassion and facts, and make it easy to take actionable steps forward. REALLY LISTEN. Not all vaccine hesitancy stems from the same concerns. Creating Read more…

Does someone who has been vaccinated still need to wear a mask and take other precautions?

Infection and Spread Vaccines

A: Yes. We don’t yet know whether the vaccines prevent someone from being infectious. The existing COVID-19 vaccine trials focused on a specific endpoint – symptomatic COVID-19 disease. We know that both the Pfizer and Moderna vaccines were close to 95% efficacious in preventing disease (YAY!!). But wouldn’t we expect the vaccine to also stop Read more…

Is there any research or guidance regarding the vaccines for those of us who already had it?

Vaccines

A: Those who have had COVID19 are recommended to receive the vaccine. Data from the Pfizer and Moderna vaccine trials demonstrated safety in participants that have had COVID19 previously. Scientists are hopeful that the vaccine will offer a higher level of protection than immunity to natural infection. Although the Pfizer and Moderna vaccine excluded participants Read more…

In vaccine trial data we trust?!

Data and Metrics Data Literacy Uncertainty and Misinformation Vaccines

A: Like a healthy democracy, a healthy data system relies on a sophisticated set of checks and balances. The FDA’s system is highly protective against data hanky-panky.* Today an FDA advisory panel meets to discuss Moderna’s vaccine data – with an eye towards recommending emergency use authorization. Your Nerdy Girls look forward to watching all Read more…

It has been a BIG day in vaccine news!

Vaccines

Today, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended the first COVID-19 vaccine! The ACIP met to review and make recommendations on the Pfizer-BioNTech COVID-19 vaccine, which was given emergency use authorization by the FDA last night. You can read all the information presented at the ACIP meeting (see the link at the bottom). Read more…